SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0000950123-11-077196
Filing Date
2011-08-15
Accepted
2011-08-15 08:00:24
Documents
10
Period of Report
2011-06-30
Filing Date Changed
2011-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c21308e10vq.htm 10-Q 183377
2 EX-10.1 c21308exv10w1.htm EX-10.1 88486
3 EX-10.2 c21308exv10w2.htm EX-10.2 80592
4 EX-10.3 c21308exv10w3.htm EX-10.3 89435
5 EX-10.4 c21308exv10w4.htm EX-10.4 49877
6 EX-10.5 c21308exv10w5.htm EX-10.5 27094
7 EX-10.6 c21308exv10w6.htm EX-10.6 27201
8 EX-31.1 c21308exv31w1.htm EX-31.1 5904
9 EX-31.2 c21308exv31w2.htm EX-31.2 6042
10 EX-32.1 c21308exv32w1.htm EX-32.1 3901
  Complete submission text file 0000950123-11-077196.txt   563086
Mailing Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111
Business Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111 (303) 867-3415
OMNI BIO PHARMACEUTICAL, INC. (Filer) CIK: 0001389870 (see all company filings)

IRS No.: 208097969 | State of Incorp.: CO | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-52530 | Film No.: 111033188
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1